Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial

Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the hepatic component of metabolic syndrome. Despite the beneficial health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no previous human study has been conducted on the efficacy of cardamom in NAFLD. T...

Full description

Bibliographic Details
Main Authors: Milad Daneshi-Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, Siavash Mansouri, Seyed Moayed Alavian, Mahtab Badri-Fariman, Seyed Ali Jazayeri-Tehrani, Gity Sotoudeh
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Nutrition & Metabolism
Subjects:
Non-alcoholic fatty liver disease
Green cardamom
Overweight or obesity
Sirtuin-1
Inflammatory factors
Online Access:http://link.springer.com/article/10.1186/s12986-018-0297-4

Internet

http://link.springer.com/article/10.1186/s12986-018-0297-4

Similar Items